Navigation Links
Paul Tornetta III, MD, Elected to American Academy of Orthopaedic Surgeons Board of Directors
Date:2/27/2009

LAS VEGAS, Feb. 27 /PRNewswire-USNewswire/ -- Orthopaedic surgeon Paul Tornetta III, MD, was elected to the Board of Directors of the American Academy of Orthopaedic Surgeons (AAOS) (http://www.aaos.org) at the organization's 2009 Annual Meeting in Las Vegas, for the Member-at-Large position.

Dr. Tornetta is currently the director of orthopaedic trauma at the Boston Medical Center and professor, vice chairman, and the residency program director of orthopaedic surgery at the Boston University School of Medicine.

"I am indeed honored," said Dr. Tornetta, "to serve on the Academy's Board of Directors. I am eager to help with the many challenges which are currently facing the orthopaedic profession."

Dr. Tornetta earned his medical degree and completed his internship and orthopaedic residency training at the State University of New York Health Science Center at Brooklyn. Following a fellowship at Hospital of the Good Samaritan in Los Angeles, California, Dr. Tornetta was appointed the director of orthopaedic Trauma at Kings County Hospital Center and the University Hospital of Brooklyn.

Devoted to teaching orthopaedic residents, Dr. Tornetta is also committed to improving the quality of patient care through his research. "I have known Dr. Tornetta for 17 years and have closely followed his career," said M. Bradford Henley, MD, professor of orthopaedics, Harborview Medical Center, University of Washington and an AAOS board member. "Throughout those years, I have been impressed by his dedication to patients, his focus on orthopaedic resident education, and his tireless commitment to the improvement and quality of orthopaedic care, education and research."

Dr. Tornetta's research interests focus on both the clinical and technical aspects of orthopaedic trauma surgery and the injured patient. Currently his studies involve elderly patients' injury patterns, fracture healing, and minimally invasive surgery. The author of more than 100 scientific papers, symposia and book chapters, Dr. Tornetta is also a three-time recipient of the Robert E. Leach Resident Teaching Award.

A former president of the Orthopaedic Trauma Association (OTA), Dr. Tornetta is currently the Chairman of the OTA Strategic Planning & Board Development Committee. He is also a member of the AAOS Instructional Course and Guidelines Oversight Committees. Dr. Tornetta serves as an associate editor for the Journal of Orthopaedic Trauma and as an editor and reviewer for the Journal of Bone and Joint Surgery, Journal of the American Academy of Orthopaedic Surgeons, and the Journal of Trauma.

"As an Academy board member," noted Dr. Tornetta, "I will work to instill a sense of urgency in making the required changes needed to provide the highest level of care for our patients, education for our colleagues, and research to improve patient outcomes."

About AAOS

http://www6.aaos.org/news/Pemr/releases/release_boiler.cfm?category=40&releasenum=735.

OTA

http://www.ota.org

    For more information, contact:

    Catherine Dolf
    C (847) 894-9112
    O (847) 384-4034
    dolf@aaos.org

    Lauren L. Pearson
    C (224) 374-8610
    O (847) 384-4031
    lpearson@aaos.org


'/>"/>
SOURCE American Academy of Orthopaedic Surgeons
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Brooke Franchise Corporation Announces Selected July Results
2. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
3. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
4. Crdentia Selected by High Rock Raceway to Provide Healthcare Staffing Services
5. Montana Health Care Leader Elected Board Chair of National Association
6. Fry Construction Selected for High-Profile Medical Imaging Project
7. John B. Buse, MD, PhD of Chapel Hill, NC, Elected American Diabetes Association President, Medicine & Science
8. Meth Project Advertisements Selected for National Prevention Campaign
9. Eight Graduate Nursing Students Selected to Receive The California Endowment-AACN Minority Nurse Faculty Scholarship
10. CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits
11. SAIC Selected to Support the U.S. Military Theater Medical Information Program-Joint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: